Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077594 · ClinicalTrials.gov registry record
Characterization of the Neo-squamous Epithelial Barrier
A clinical trial of Barretts Esophagus With Dysplasia, sponsored by Mayo Clinic.
- Completed
- Registry status
- 53
- Enrollment target
- 2
- Study locations
NCT03077594: Completed study of Barretts Esophagus With Dysplasia, sponsored by Mayo Clinic.
NCT03077594 is a study of Barretts Esophagus With Dysplasia that has completed, run by Mayo Clinic. The registered enrollment target is 53 participants, below the 700-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03077594, a study of Barretts Esophagus With Dysplasia, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
- 2
- Study locations
Study Summary
To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular space dilation in patients who have successfully completed endoscopic radiofrequency ablation versus balloon cryotherapy for Barrett's Esophagus related metaplasia.
Primary Outcome
Assess the mucosal impedance of neosquamous epithelium after successful treatment of Barrett's Esophagus.
Conditions Studied
Interventions
- DEVICE Mucosal Impedance
- OTHER Research Biopsies
- DEVICE Volumetric Laser Endomicroscopy
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-09-26 |
| Est. Completion | 2022-06-29 |
What the finished NCT03077594 record still lists
NCT03077594 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 700-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Barretts Esophagus With Dysplasia appearing as the primary indexed condition, and to 3 interventions - of which Mucosal Impedance is the first listed.
NCT03077594 reports a single indexed study location in Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT03077594 about?
NCT03077594 is a clinical study titled "Characterization of the Neo-squamous Epithelial Barrier". To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular space dilation in patients who have successfully completed endoscopic radiofrequency ablation versus balloon cryotherapy for Barrett's Esopha...
What is the current status of trial NCT03077594?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2016-09-26. Estimated completion is 2022-06-29.
What conditions does trial NCT03077594 study?
This clinical trial studies the following conditions: Barretts Esophagus With Dysplasia.
What interventions are being tested in trial NCT03077594?
The interventions under investigation include: Mucosal Impedance (DEVICE), Research Biopsies (OTHER), Volumetric Laser Endomicroscopy (DEVICE).
Who is sponsoring clinical trial NCT03077594?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03077594 being conducted?
This trial has 2 study locations across Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barretts Esophagus With Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
-
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
RECRUITING · NA
-
Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
ACTIVE NOT RECRUITING
-
The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI